Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16687
Country/Region: Kenya
Year: 2016
Main Partner: Health Strat
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $1,593,199 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $196,030
Care: TB/HIV (HVTB) $111,720
Care: Pediatric Care and Support (PDCS) $36,604
Health Systems Strengthening (OHSS) $160,000
Testing: HIV Testing and Counseling (HVCT) $141,865
Sexual Prevention: Other Sexual Prevention (HVOP) $378,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $102,688
Treatment: Adult Treatment (HTXS) $411,387
Treatment: Pediatric Treatment (PDTX) $54,905
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Age/sex: <1 2017 47
HTS_TST Age/sex: 1-9 2017 413
HTS_TST Age/sex: 10-14 Female 2017 728
HTS_TST Age/sex: 10-14 Male 2017 1,221
HTS_TST Age/sex: 15-19 Female 2017 3,259
HTS_TST Age/sex: 15-19 Male 2017 7,424
HTS_TST Age/sex: 20-24 Female 2017 12,858
HTS_TST Age/sex: 20-24 Male 2017 24,363
HTS_TST Age/sex: 25-49 Female 2017 16,257
HTS_TST Age/sex: 25-49 Male 2017 29,581
HTS_TST Age/sex: 50+ Female 2017 3,195
HTS_TST Age/sex: 50+ Male 2017 6,136
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 886
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,530
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 35,798
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 68,555
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 106,769
HTS_TST Service Delivery Point (Facility): Index testing 2017 1,452
HTS_TST Service Delivery Point (Facility): Inpatient 2017 5,995
HTS_TST Service Delivery Point (Facility): Other PITC 2017 791
HTS_TST Service Delivery Point (Facility): Outpatient 2017 64,576
HTS_TST Service Delivery Point (Facility): Pediatric 2017 1,038
HTS_TST Service Delivery Point (Facility): PMTCT 2017 5,994
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 222
HTS_TST Service Delivery Point (Facility): VCT 2017 25,856
HTS_TST Service Delivery Point (Facility): VMMC 2017 845
HTS_TST Sum of Age/Sex disaggregates 2017 105,022
HTS_TST Sum of Aggregated Age/Sex <15 2017 2,416
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 104,353
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 106,769
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 13
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 23
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 89
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 130
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 327
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 495
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 381
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 579
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 76
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 102
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 44
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 55
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,820
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 2,749
PMTCT_ART Already on ART at beginning of current pregnancy 2017 263
PMTCT_ART New on ART 2017 92
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 6,776
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 187
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 75
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 12
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 6
PMTCT_EID Sum of Infant Age disaggregates 2017 262
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 20
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 103
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 663
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 1,414
PMTCT_STAT By: Known positives at entry 2017 240
PMTCT_STAT By: Number of new positives identified 2017 86
PMTCT_STAT Number of new ANC and L&D clients 2017 6,776
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 6,776
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 9
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 60
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 12
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 4
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 19
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 4
PMTCT_STAT Sum of Positives Status disaggregates 2017 326
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 20
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 103
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 663
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 1,414
PP_PREV Aggregated Age/sex: 15+ Female 2017 22,484
PP_PREV Aggregated Age/sex: 15+ Male 2017 31,516
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 54,000
PP_PREV Total number of people in the target population 2017 54,000
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 37
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 128
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 53
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 172
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 390
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 390
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,152
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,152
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,275
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 2,777
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 3,389
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 102
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 100
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 6,368
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 85
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 511
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 113
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 600
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,309
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,309
TX_CURR Age/Sex: <1-9 2017 141
TX_CURR Age/Sex: 10-14 Female 2017 32
TX_CURR Age/Sex: 10-14 Male 2017 29
TX_CURR Age/Sex: 15-19 Female 2017 68
TX_CURR Age/Sex: 15-19 Male 2017 84
TX_CURR Age/Sex: 20-24 Female 2017 242
TX_CURR Age/Sex: 20-24 Male 2017 167
TX_CURR Age/Sex: 25-49 Female 2017 2,057
TX_CURR Age/Sex: 25-49 Male 2017 2,346
TX_CURR Age/Sex: 50+ Female 2017 410
TX_CURR Age/Sex: 50+ Male 2017 792
TX_CURR Aggregated Age/Sex: <15 Female 2017 102
TX_CURR Aggregated Age/Sex: <15 Male 2017 100
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,777
TX_CURR Aggregated Age/Sex: 15+ Male 2017 3,389
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 6,368
TX_CURR Sum of age/sex disaggregates 2017 152
TX_CURR Sum of Aggregated Age/Sex <15 2017 202
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 6,166
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 6,368
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 47
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 44
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 1,087
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 1,136
TX_NEW By Age/Sex: <1 2017 5
TX_NEW By Age/Sex: 1-9 2017 37
TX_NEW By Age/Sex: 10-14 Female 2017 27
TX_NEW By Age/Sex: 10-14 Male 2017 21
TX_NEW By Age/Sex: 15-19 Female 2017 14
TX_NEW By Age/Sex: 15-19 Male 2017 12
TX_NEW By Age/Sex: 20-24 Female 2017 87
TX_NEW By Age/Sex: 20-24 Male 2017 59
TX_NEW By Age/Sex: 25-49 Female 2017 803
TX_NEW By Age/Sex: 25-49 Male 2017 804
TX_NEW By Age/Sex: 50+ Female 2017 183
TX_NEW By Age/Sex: 50+ Male 2017 262
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,314
TX_NEW Sum of Age/Sex disaggregates 2017 2,272
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 2,314
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 5,749
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 5,749
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 96
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 95
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,504
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 3,054
TX_PVLS Numerator: Indication: Routine 2017 5,749
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 95
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 95
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 2,504
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 3,054
TX_PVLS_den Denominator: Indication: Routine 2017 5,749
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 37
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 26
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 12
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 79
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 52
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 710
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 730
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 162
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 236
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 45
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 44
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 964
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,030
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 2,083
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 2,314
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 37
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 28
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 20
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 13
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 88
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 61
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 803
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 803
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 183
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 261
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 47
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 44
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,087
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,136
Cross Cutting Budget Categories and Known Amounts Total: $316,011
Human Resources for Health $308,303
Gender: Gender Based Violence (GBV) $3,854
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Gender: Gender Equality $3,854
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research